Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of Losartan 100 mg vs COZAAR 100 mg in healthy Thai volunteers (fasting)
TCTR20211117004Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of losartan in hypertension (HTN) (2 arms), sponsored by Bio-innova. Planned start Apr 2022; status: not yet recruiting.
02
Drugs
losartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on TCTR20211117004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20211117004.